Organogenesis Holdings Stock Performance

Organogenesis Holdings Relative Risk vs. Return Landscape

If you would invest  648.00  in Organogenesis Holdings on November 12, 2025 and sell it today you would lose (265.00) from holding Organogenesis Holdings or give up 40.9% of portfolio value over 90 days. Organogenesis Holdings is currently does not generate positive expected returns and assumes 3.8485% risk (volatility on return distribution) over the 90 days horizon. In different words, 34% of stocks are less volatile than Organogenesis, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.Given the investment horizon of 90 days Organogenesis Holdings is expected to under-perform the market. In addition to that, the company is 4.75 times more volatile than its market benchmark. It trades about -0.21 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.08 per unit of volatility.

Organogenesis Holdings Target Price Odds to finish over Current Price

Given the investment horizon of 90 days the stock has the beta coefficient of 1.53 . This indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Organogenesis Holdings will likely underperform. Additionally Organogenesis Holdings has an alpha of 0.0416, implying that it can generate a 0.0416 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).

Predictive Modules for Organogenesis Holdings

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Organogenesis Holdings. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Hype Prediction Low Estimated High 0.17 3.41 7.20 Details

Intrinsic Valuation Low Real High 1.17 4.96 8.75 Details

4 Analysts Consensus Low Target High 7.74 8.50 9.44 Details

Earnings Estimates (0) Low Projected EPS High -0.09 -0.09 -0.09 Details

Please note, it is not enough to conduct a financial or market analysis of a single entity such as Organogenesis Holdings. Your research has to be compared to or analyzed against Organogenesis Holdings' peers to derive any actionable benefits. When done correctly, Organogenesis Holdings' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Organogenesis Holdings.

Organogenesis Holdings Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Organogenesis Holdings is not an exception. The market had few large corrections towards the Organogenesis Holdings' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Organogenesis Holdings, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Organogenesis Holdings within the framework of very fundamental risk indicators.

Organogenesis Holdings Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Organogenesis Holdings for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Organogenesis Holdings can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.

Organogenesis Holdings Price Density Drivers

Organogenesis Holdings Fundamentals Growth

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Organogenesis Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. To learn how to invest in Organogenesis Stock, please use our How to Invest in Organogenesis Holdings guide.You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Investors evaluate Organogenesis Holdings using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Organogenesis Holdings' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Organogenesis Holdings' market price to deviate significantly from intrinsic value.

It's important to distinguish between Organogenesis Holdings' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Organogenesis Holdings should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Organogenesis Holdings' market price signifies the transaction level at which participants voluntarily complete trades.